glp-1 digital health platform startups Novo Nordisk seeks partners to boost GLP-1RA weight loss outcomes Beyond the Hype: Where and

Below is a breakdown of compatibility

Given our findings, future research with Dandelion data will focus on (i) investigating the heterogeneity in treatment response to GLP-1s, (ii) modeling predictors of patient responsiveness, and (iii) analyzing unstructured clinical data to understand the impact of GLP-1s on measures beyond weight loss and HbA1c (e.g., loss or preservation of lean body mass)

Combining GLP-1 meds with training and protein is critical to reduce fall risk and preserve strength

GlucoVantage is up to 5x more effective than standard Berberine, delivering powerful metabolic benefits with a smaller dose

It is also independently associated with cardiovascular morbidity and mortality

19 , e240046 (2024)